Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gregory T Wolf

Showing results (21-30 of 217) with videos related to

Pageof 22
Sort By:
Oral Oncology|October 30, 2021
Characterization of the immune response in patients with cancer of the oral cavity after neoadjuvant immunotherapy with the IRX-2 regimenSiyu Liu, Emily Bellile, Ariane Nguyen, et al.
Expert Review of Anticancer Therapy|September 24, 2013
Chemoselection: a paradigm for optimization of organ preservation in locally advanced larynx cancerJeffrey M Vainshtein, Vivian F Wu, Matthew E Spector, et al.
The Laryngoscope|May 15, 2018
Vitamin D intake and survival and recurrence in head and neck cancer patientsEva B Yokosawa, Anna E Arthur, Katie M Rentschler, et al.
Head & Neck|October 30, 2013
Phase II trial of biweekly gemcitabine and paclitaxel with recurrent or metastatic squamous cell carcinoma of the head and neck: Southwest Oncology Group study S0329Binu Malhotra, James Moon, Omar Kucuk, et al.
Oral Oncology|August 25, 2016
Telltale tumor infiltrating lymphocytes (TIL) in oral, head & neck cancerYu Lei, Yuying Xie, Yee Sun Tan, et al.
Archives of Otolaryngology--Head & Neck Surgery|July 16, 2002
Neck dissection classification update: revisions proposed by the American Head and Neck Society and the American Academy of Otolaryngology-Head and Neck SurgeryK Thomas Robbins, Garry Clayman, Paul A Levine, et al.
Cancer Treatment Reviews|November 2, 2013
Targeted therapies for squamous cell carcinoma of the head and neck: current knowledge and future directionsSandra Schmitz, Kie Kian Ang, Jan Vermorken, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 26, 2010
Phase II evaluation of sorafenib in advanced and metastatic squamous cell carcinoma of the head and neck: Southwest Oncology Group Study S0420Stephen K Williamson, James Moon, Chao H Huang, et al.
Head & Neck|October 13, 2011
Evidence-based review of treatment options for patients with glottic cancerDana M Hartl, Alfio Ferlito, Daniel F Brasnu, et al.
The Laryngoscope|August 2, 2002
Tumor angiogenesis as a predictive marker for organ preservation in patients with advanced laryngeal carcinomaTheodoros N Teknos, Claudell Cox, Martin A Barrios, et al.
Pageof 22

Showing results (21-30 of 217) with videos related to

Sort By:
Pageof 22
Oral Oncology|October 30, 2021
Characterization of the immune response in patients with cancer of the oral cavity after neoadjuvant immunotherapy with the IRX-2 regimenSiyu Liu, Emily Bellile, Ariane Nguyen, et al.
Expert Review of Anticancer Therapy|September 24, 2013
Chemoselection: a paradigm for optimization of organ preservation in locally advanced larynx cancerJeffrey M Vainshtein, Vivian F Wu, Matthew E Spector, et al.
The Laryngoscope|May 15, 2018
Vitamin D intake and survival and recurrence in head and neck cancer patientsEva B Yokosawa, Anna E Arthur, Katie M Rentschler, et al.
Head & Neck|October 30, 2013
Phase II trial of biweekly gemcitabine and paclitaxel with recurrent or metastatic squamous cell carcinoma of the head and neck: Southwest Oncology Group study S0329Binu Malhotra, James Moon, Omar Kucuk, et al.
Oral Oncology|August 25, 2016
Telltale tumor infiltrating lymphocytes (TIL) in oral, head & neck cancerYu Lei, Yuying Xie, Yee Sun Tan, et al.
Archives of Otolaryngology--Head & Neck Surgery|July 16, 2002
Neck dissection classification update: revisions proposed by the American Head and Neck Society and the American Academy of Otolaryngology-Head and Neck SurgeryK Thomas Robbins, Garry Clayman, Paul A Levine, et al.
Cancer Treatment Reviews|November 2, 2013
Targeted therapies for squamous cell carcinoma of the head and neck: current knowledge and future directionsSandra Schmitz, Kie Kian Ang, Jan Vermorken, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 26, 2010
Phase II evaluation of sorafenib in advanced and metastatic squamous cell carcinoma of the head and neck: Southwest Oncology Group Study S0420Stephen K Williamson, James Moon, Chao H Huang, et al.
Head & Neck|October 13, 2011
Evidence-based review of treatment options for patients with glottic cancerDana M Hartl, Alfio Ferlito, Daniel F Brasnu, et al.
The Laryngoscope|August 2, 2002
Tumor angiogenesis as a predictive marker for organ preservation in patients with advanced laryngeal carcinomaTheodoros N Teknos, Claudell Cox, Martin A Barrios, et al.
Pageof 22